Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

MIST holding history

Milestone Pharmaceuticals Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MIST overviewAll 13F holders of MISTFull Q2 2026 holdings

Shares (Q2 2026)
465,403
Value
$623.6K
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of MIST by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026465,403$623.6K<0.1%−29,505−6.0%ReducedHolders
Q1 2026494,908$588.9K<0.1%+3,040+0.6%AddedHolders
Q4 2025491,868$993.6K<0.1%+94,334+23.7%AddedHolders
Q3 2025397,534$795.1K<0.1%+74,886+23.2%AddedHolders
Q2 2025322,648$625.9K<0.1%+211,125+189.3%AddedHolders
Q1 2025111,523$89.2K<0.1%+22,017+24.6%AddedHolders
Q4 202489,506$211.2K<0.1%+89,506NewHolders
Q2 20240$00.0%−2,618−100.0%Sold outHolders
Q1 20242,618$4.69K<0.1%+2,618NewHolders
Q4 20230$00.0%−1,693−100.0%Sold outHolders
Q3 20231,693$5.25K<0.1%−1,644−49.3%ReducedHolders
Q2 20233,337$9.51K<0.1%+565+20.4%AddedHolders
Q1 20232,772$10.9K<0.1%−2,413−46.5%ReducedHolders
Q4 20225,185$20.5K<0.1%+1,865+56.2%AddedHolders
Q3 20223,320$31.0K<0.1%+2,304+226.8%AddedHolders
Q2 20221,016$6.00K<0.1%+1,016NewHolders
Q1 20220$00.0%−1,031−100.0%Sold outHolders
Q4 20211,031$7.00K<0.1%+1,031NewHolders
Q3 20210$00.0%−483−100.0%Sold outHolders
Q2 2021483$3.00K<0.1%−13,016−96.4%ReducedHolders
Q1 202113,499$78.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.